Image
MIT and Takeda Pharmaceuticals
MIT news article

The MIT-Takeda Program aims to fuel the development and application of artificial intelligence (AI) capabilities to benefit human health and drug development. Centered within the Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic), the program brings together the MIT School of Engineering and Takeda Pharmaceuticals, to combine knowledge and address challenges of mutual interest.

Image
immune system molecule
MIT news article

More than a decade before people with Huntington’s disease (HD) show symptoms, they can exhibit abnormally high levels of an immune-system molecule called interleukin-6 (IL-6), which has led many researchers to suspect IL-6 of promoting the eventual neurological devastation associated with the genetic condition.

Image
City of Boston
CSAIL article

In our current and evolving circumstances surrounding the novel coronavirus outbreak, we are advised to avoid sharing rides with other passengers as part of the effort to slow the spread of the disease. As in other markets, these necessary practices are impacting the shared transportation industry. But some businesses are rising to the challenge and rethinking how they use their existing ride-sharing technology to help during the crisis.